Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma

Mathew R. Birnbaum, Michelle W. Ma, Sarah Fleisig, Stuart Packer, Bijal D. Amin, Mark Jacobson, Beth N. McLellan

Research output: Contribution to journalArticle

30 Scopus citations
Original languageEnglish (US)
Pages (from-to)208-211
Number of pages4
JournalJAAD Case Reports
Volume3
Issue number3
DOIs
StatePublished - May 1 2017

Keywords

  • immune checkpoint inhibitors
  • immune-related adverse events
  • immunotherapy
  • nivolumab
  • programmed cell death-1
  • sarcoidosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this